These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4345845)

  • 21. Human fascioliasis (distomatosis).
    Crokaert F; Glupczynski Y; Yourassowsky E; Kutnowski M; Verbanck M
    J Infect; 1984 Jul; 9(1):101-2. PubMed ID: 6389708
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical and therapeutic aspects of hepatic distomatosis].
    Monange C; Gisselbrecht H
    Sem Hop; 1970 Sep; 46(37):2374-7. PubMed ID: 4319030
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neurologic manifestation of hepatic distomatosis due to Fasciola hepatica].
    Domart A; Gentilini M; Brion S; Carbon C
    Bull Mem Soc Med Hop Paris; 1967 Jun 2-9; 118(9):839-47. PubMed ID: 6060530
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comments on an epidemic of human hepatic distomatosis. Study of 50 cases in a hospital milieu].
    Giraudet J
    Presse Med (1893); 1968 Jan; 76(5):189-92. PubMed ID: 5638169
    [No Abstract]   [Full Text] [Related]  

  • 25. Fasciola hepatica: antibody levels in sheep serum before and after treatment with anthelmintic.
    Hanna RE; Hughes DL; Taylor SM
    Res Vet Sci; 1982 Nov; 33(3):328-32. PubMed ID: 6760303
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fasciola hepatica. Review and current status of the disease].
    Campo JM; Milazzo A; Pascual J; Salcedo J; Labarga P; Yanguela J
    Rev Clin Esp; 1984 May; 173(4):191-7. PubMed ID: 6237392
    [No Abstract]   [Full Text] [Related]  

  • 27. Infection with Fasciola hepatica.
    Aksoy DY; Kerimoglu U; Oto A; Erguven S; Arslan S; Unal S; Batman F; Bayraktar Y
    Clin Microbiol Infect; 2005 Nov; 11(11):859-61. PubMed ID: 16216098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indirect evidence of ectopic pancreatic fascioliasis in a human.
    Lee OJ; Kim TH
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1631-3. PubMed ID: 16928233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Distomatosis caused by Fasciola hepatica. Study of an epidemic outbreak].
    Alcoba Leza M; Costilla S; Cabreros Pisonero E; Jiménez García de la Marina JM; Carro JA; López González R; Jorquera F; Martínez Ramos C; Pérez Simón MR
    Rev Esp Enferm Apar Dig; 1988 Nov; 74(5):509-14. PubMed ID: 3238154
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neurologic and cardiac symptoms in a Fasciola hepatica infection].
    Kristoferitsch W; Wessely P; Auer H; Picher O
    Nervenarzt; 1982 Dec; 53(12):710-3. PubMed ID: 7155232
    [No Abstract]   [Full Text] [Related]  

  • 31. Human fascioliasis: cure by mebendazole? A case report.
    Dugernier T; Geubel A; Bigaignon G; Cesbron JY; Coche E
    Gastroenterol Clin Biol; 1986; 10(6-7):513-6. PubMed ID: 3758595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Passive hemagglutination test in the diagnosis of fascioliasis (fasciola hepatica) in humans].
    Jedrzejewska B; Płonka WS
    Przegl Epidemiol; 1983; 37(3-4):369-74. PubMed ID: 6665195
    [No Abstract]   [Full Text] [Related]  

  • 33. Fasciola hepatica in a New Zealander traveler.
    Kang ML; Teo CH; Wansaicheong GK; Giron DM; Wilder-Smith A
    J Travel Med; 2008; 15(3):196-9. PubMed ID: 18494697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pruritus and intermittent jaundice as clinical clues for Fasciola hepatica infestation.
    Umac H; Erkek AB; Ayaşlioğlu E; Erkek E; Ozluk U; Onen N
    Liver Int; 2006 Aug; 26(6):752-3. PubMed ID: 16842334
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatic fascioliasis due to Fasciola hepatica: a two-case report.
    Aroonroch R; Worawichawong S; Nitiyanant P; Kanchanapitak A; Bunyaratvej S
    J Med Assoc Thai; 2006 Oct; 89(10):1770-4. PubMed ID: 17128857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human fasciolosis diagnosed in the acute phase: A first clinical report in Mexico.
    Cruz Y López OR; Gómez de la Vega E; Cárdenas-Perea ME; Gutiérrez-Dávila A; Tamariz-Cruz OJ
    Rev Gastroenterol Mex; 2016; 81(2):111-3. PubMed ID: 26253889
    [No Abstract]   [Full Text] [Related]  

  • 37. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS; Brodie SB; Weller PF
    Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical tumor caused by the sexually mature stage of Fasciola hepatica.
    Marcos LA; Légua P; Sánchez J; Espinoza JR; Yi P; Tantaleán M
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):318-20. PubMed ID: 19046753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inflammatory pseudotumor by Fasciola hepática: a case report].
    Tume-Jara L; Ugarte-Salvador C; Díaz-Ferrer J; Piscoya A
    Rev Chilena Infectol; 2015 Dec; 32(6):703-5. PubMed ID: 26928509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fascioliasis: diagnosis, epidemiology and treatment].
    Carrada-Bravo T
    Rev Gastroenterol Mex; 2003; 68(2):135-42. PubMed ID: 15127652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.